Phase 1 Clinical Trial of the Safety and Immunogenicity of an Adenovirus-based TB Vaccine Administered by Aerosol

NCT02337270 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

36

Enrollment

OTHER

Sponsor class

Conditions

Tuberculosis

Interventions

BIOLOGICAL: Ad5Ag85A

Sponsor

McMaster University

Collaborators

[object Object]